{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T11:45:21Z","timestamp":1778154321778,"version":"3.51.4"},"reference-count":24,"publisher":"Medical Association of Zenica-Doboj","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicinski Glasnik"],"published-print":{"date-parts":[[2022,7,2]]},"abstract":"<jats:p>&amp;lt;p&amp;gt;Pheochromocytoma is a rare cause of hypertension in pregnancy. Unrecognized, it carries a great risk for both mother and the foetus. The main reason for missing the diagnosis is the misconception that any hypertension occurring in pregnancy is gestational hypertension or pre (eclampsia). As many as 90% of patients report one or more pheochromocytoma-related symptoms antenatally, but the diagnosis is made in 75% of patients, meaning that 3 out of 10 patients are diagnosed after childbirth or post-mortem. The symptoms are similar to other more common causes of hypertension in pregnancy, which presents a major diagnostic challenge. The diagnosis is based on determination of metanephrines in plasma or 24-hour urine. Magnetic resonance imaging (MRI) and ultrasound (US) are used to localize the tumour. If the diagnosis is made before the 24th week of pregnancy, laparoscopic removal of the tumour in the second trimester is recommended. If diagnosed later, the tumour could be removed during or after delivery. Preoperative preparation with alpha blockers is required to stabilize blood pressure. The decision on the mode of delivery depends on several factors, so an experienced multidisciplinary team is needed to minimize maternal and foetal mortality.&amp;lt;\/p&amp;gt;<\/jats:p>","DOI":"10.17392\/1474-22","type":"journal-article","created":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T10:28:16Z","timestamp":1713695296000},"page":"100-105","source":"Crossref","is-referenced-by-count":3,"title":["Pheochromocytoma in pregnancy \u2013 a rare but dangerous diagnosis"],"prefix":"10.17392","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0392-2943","authenticated-orcid":false,"given":"Romana","family":"Maru\u0161i\u0107","sequence":"first","affiliation":[{"name":"National Memorial Hospital Vukovar","place":["Vukovar,Croatia"],"department":["Department of Internal Medicine"]},{"name":"J. J. Strossmayer University","place":["Osijek,Croatia"],"department":["School of Medicine"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marija","family":"Oluji\u0107","sequence":"additional","affiliation":[{"name":"School of Medicine, J. J. Strossmayer University, Osijek"},{"name":"Clinical Hospital Centre, Rijeka","place":["Rijeka,Croatia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatjana","family":"Ba\u010dun","sequence":"additional","affiliation":[{"name":"School of Medicine, J. J. Strossmayer University","place":["Osijek,Croatia"]},{"name":"University Hospital Centre, Osijek","place":["Osijek,Croatia"],"department":["Department of Internal Medicine, Division of Endocrinology"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"49509","published-online":{"date-parts":[[2022,7,2]]},"reference":[{"key":"ref1","first-page":"605","author":"JwmLendersJwm","year":"2019","unstructured":"Lenders JWM, Langton K, Langenhuijsen JF, Eise-\nnhofer G. Pheochromocytoma and Pregnancy. En-\ndocrinol Metab Clin North Am 2019; 48:605-617.","journal-title":"Pheochromocytoma and Pregnancy. Endocrinol Metab Clin North Am"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2478\/enr-2019-0020","author":"FFarrugiaF","year":"2019","unstructured":"Farrugia FA, Charalampopoulos A. Pheochro-\nmocytoma. Endocr Regul 2019; 53:191-212.","journal-title":"Endocr Regul"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1530\/EJE-16-0920","article-title":"Endocrinology in pregnancy: Pheochromocytoma in pregnancy: case series and review of literature","author":"KVan Der WeerdK","year":"2017","unstructured":"van der Weerd K, van Noord C, Loeve M, Knapen \nMFCM, Visser W, de Herder WW, Franssen G, van \nder Marel CD, Feelders RA. Endocrinology in pre-\ngnancy: Pheochromocytoma in pregnancy: case se-\nries and review of literature. Eur J Endocrinol 2017; \n177:R49-58.","journal-title":"Eur J Endocrinol"},{"key":"ref4","first-page":"829","article-title":"Evaluation and management of endocrine hypertension during pregnancy","author":"SCorselloS","year":"2019","unstructured":"Corsello SM, Paragliola RM. Evaluation and ma-\nnagement of endocrine hypertension during pre-\ngnancy. Endocrinol Metab Clin North Am 2019; \n48:829-42.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref5","first-page":"480","article-title":"Pheochromocytoma during pregnancy: case report and review of recent literature","author":"LOrioliL","year":"2017","unstructured":"Orioli L, Debi\u00e8ve F, Donckier J, Mourad M, Lois \nF, Maiter D. Pheochromocytoma during pregnancy: \ncase report and review of recent literature. Ann En-\ndocrinol (Paris) 2017; 78:480-4.","journal-title":"Ann Endocrinol"},{"key":"ref6","first-page":"496","article-title":"Pheochromocytoma and pregnancy: A case report and review","author":"DSantosD","year":"2015","unstructured":"Santos DR, Barbisan CC, Marcellini C, dos Santos \nRM. Pheochromocytoma and pregnancy: A case re-\nport and review. J Bras Nefrol 2015; 37:496-500.","journal-title":"J Bras Nefrol"},{"key":"ref7","first-page":"300","article-title":"Pheochromocytoma and pregnancy: a rare but dangerous combination","author":"VSarathiV","year":"2010","unstructured":"Sarathi V, Lila AR, Bandgar TR, Menon PS, Shah NS. \nPheochromocytoma and pregnancy: a rare but dange-\nrous combination. Endocr Pract 2010; 16:300-9.","journal-title":"Endocr Pract"},{"key":"ref8","first-page":"1094","article-title":"Preeclampsia: Pathophysiology, challenges, and perspectives","author":"SRanaS","year":"2019","unstructured":"Rana S, Lemoine E, Granger JP, Karumanchi SA. \nPreeclampsia: Pathophysiology, challenges, and per-\nspectives. Circ Res 2019; 124:1094-112.","journal-title":"Circ Res"},{"key":"ref9","first-page":"152","article-title":"Update on modern management of pheochromocytoma and paraganglioma","author":"JwmLendersJwm","year":"2017","unstructured":"Lenders JWM, Eisenhofer G. Update on modern \nmanagement of pheochromocytoma and paragan-\nglioma. Endocrinol Metab (Seoul) 2017; 32:152-61.","journal-title":"Endocrinol Metab (Seoul)"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-16-0033","article-title":"Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma","author":"PPlouinP","year":"2016","unstructured":"Plouin PF, Amar L, Dekkers OM, Fassnacht M, Gi-\nmenez-Roqueplo AP, Lenders JW, Lussey-Lepoutre \nC, Steichen O; Guideline Working Group. European \nSociety of Endocrinology Clinical Practice Guideli-\nne for long-term follow-up of patients operated on \nfor a phaeochromocytoma or a paraganglioma. Eur J \nEndocrinol 2016; 174:G1-10.","journal-title":"Eur J Endocrinol"},{"key":"ref11","first-page":"315","article-title":"Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma","author":"KPacakK","year":"2001","unstructured":"Pacak K, Linehan M, Eisenhofer G, Walther MM, \nGoldstein DS. Recent advances in genetics, diagno-\nsis, localization, and treatment of pheochromocyto-\nma. Annals of Internal Medicine 2001; 134:315-29.","journal-title":"Annals of Internal Medicine"},{"key":"ref12","first-page":"1450","article-title":"Current approach to pheochromocytoma","author":"CSturgeonC","year":"2006. 1446","unstructured":"Sturgeon C, Angelos P. Current approach to pheo-\nchromocytoma. Oncology (Williston Park) 2006; \n20:1444,1446,1450-1.","journal-title":"Oncology"},{"key":"ref13","article-title":"ans that 3 out of 10 patients are diagnosed after childbirth or post-mortem (1)","unstructured":"ans that 3 out of 10 patients are diagnosed after \nchildbirth or post-mortem (1)."},{"key":"ref14","article-title":"In conclusion, early diagnosis of pheochromocytoma significantly reduces the risk to mother and child and helps prevent potential complications. FUNDING No specific funding was received for this study. TRANSPARENCY DECLARATION Competing interests: None to declare","unstructured":"In conclusion, early diagnosis of pheochro-\nmocytoma significantly reduces the risk to \nmother and child and helps prevent potential \ncomplications. \nFUNDING \nNo specific funding was received for this study. \nTRANSPARENCY DECLARATION \nCompeting interests: None to declare."},{"key":"ref15","first-page":"509","article-title":"Textbook of Endocrinology","author":"HKronenbergH","year":"2007","unstructured":"Kronenberg HM, Melmed S, Polonsky KS, Reed \nLarsen P. Williams Textbook of Endocrinology. 11th \ned. Philadelphia: Saunders 2007; 509-520."},{"key":"ref16","first-page":"1386","article-title":"Pheochromocytoma Characteristics and behaviour differ depending on method of discovery","author":"LGruberL","year":"2019","unstructured":"Gruber LM, Hartman RP, Thompson GB, McKenzie \nTJ, Lyden ML, Dy BM, Young WF, Bancos I. Pheo-\nchromocytoma Characteristics and behaviour differ \ndepending on method of discovery. J Clin Endocri-\nnol Metab 2019; 104:1386-93.","journal-title":"J Clin Endocrinol Metab"},{"key":"ref17","first-page":"135","article-title":"Pheochromocytoma and paraganglioma: genetics, diagnosis, and treatment","author":"LFishbeinL","year":"2016","unstructured":"Fishbein L. Pheochromocytoma and paraganglioma: \ngenetics, diagnosis, and treatment. Hematol Oncol \nClin North Am 2016; 30:135-50.","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref18","first-page":"665","author":"JwmLendersJwm","year":"2005","unstructured":"Lenders JWM, Eisenhofer G, Mannelli M, Pacak K. \nPhaeochromocytoma. Lancet 2005; 366:665-75.","journal-title":"Lancet"},{"key":"ref19","first-page":"205","article-title":"Feokromocitom -dijagnosti\u010dki i terapijski izazov koji traje. (Pheochromocytoma -an ongoing diagnostic and therapeutic challenge)","author":"TRon\u010devi\u0107T","year":"2007","unstructured":"Ron\u010devi\u0107 T, \u017deljkovi\u0107-Vrki\u0107 T, Kos J, Fi\u0161trek M. \nFeokromocitom -dijagnosti\u010dki i terapijski izazov \nkoji traje. (Pheochromocytoma -an ongoing diag-\nnostic and therapeutic challenge) [in Croatian] Me-\ndicus 2007; 16:205-7."},{"key":"ref20","first-page":"141","article-title":"An update on the genetics of pheochromocytoma","author":"DKarasekD","year":"2013","unstructured":"Karasek D, Shah U, Frysak Z, Stratakis C, Pacak K. \nAn update on the genetics of pheochromocytoma. J \nHum Hypertens 2013; 27:141-7.","journal-title":"J Hum Hypertens"},{"key":"ref21","first-page":"4498","article-title":"Kebebew E. Pheochromocytoma screening initiation and frequency in von Hippel-Lindau syndrome","author":"RAufforthR","year":"2015","unstructured":"Aufforth RD, Ramakant P, Sadowski SM, Mehta A, \nTrebska-McGowan K, Nilubol N, Pacak K, Kebe-\nbew E. Pheochromocytoma screening initiation and \nfrequency in von Hippel-Lindau syndrome. J Clin \nEndocrinol Metab 2015; 100:4498-504.","journal-title":"J Clin Endocrinol Metab"},{"key":"ref22","first-page":"943","article-title":"European-American Paraganglioma Study Group. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations","author":"HNeumannH","year":"2004","unstructured":"Neumann HP, Pawlu C, Peczkowska M, Bausch \nB, McWhinney SR, Muresan M, Buchta M, Fran-\nke G, Klisch J, Bley TA, Hoegerle S, Boedeker CC, \nOpocher G, Schipper J, Januszewicz A, Eng C; Eu-\nropean-American Paraganglioma Study Group. Dis-\ntinct clinical features of paraganglioma syndromes \nassociated with SDHB and SDHD gene mutations. \nJAMA 2004; 292:943-51.","journal-title":"JAMA"},{"key":"ref23","first-page":"1264","article-title":"Pregnancy and phaeochromocytoma\/paraganglioma: clinical clues affecting diagnosis and outcome -a systematic review","author":"KLangtonK","year":"2021","unstructured":"Langton K, Tufton N, Akker S, Deinum J, Eisenho-\nfer G, Timmers H, Spaanderman M, Lenders J. Pre-\ngnancy and phaeochromocytoma\/paraganglioma: \nclinical clues affecting diagnosis and outcome -a \nsystematic review. BJOG 2021; 128:1264-72.","journal-title":"BJOG"},{"key":"ref24","first-page":"3890","article-title":"Pheochromocytoma diagnosed during pregnancy: lessons learned from a series of ten patients","author":"GDonatiniG","year":"2018","unstructured":"Donatini G, Kraimps JL, Caillard C, Mirallie E, \nPierre F, De Calan L, Hamy A, Larin O, Tovkay O, \nCherenko S. Pheochromocytoma diagnosed during \npregnancy: lessons learned from a series of ten pati-\nents. Surg Endosc 2018; 32:3890-900.","journal-title":"Surg Endosc"}],"container-title":["Medicinski Glasnik"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/medicinskiglasnik.ba\/article\/1842\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicinskiglasnik.ba\/article\/1842\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T09:44:35Z","timestamp":1775468675000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicinskiglasnik.ba\/article\/id\/303\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,2]]},"references-count":24,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,7,2]]},"published-print":{"date-parts":[[2022,7,2]]}},"URL":"https:\/\/doi.org\/10.17392\/1474-22","archive":["Internet Archive"],"relation":{},"ISSN":["1840-0132","1840-0132"],"issn-type":[{"value":"1840-0132","type":"electronic"},{"value":"1840-0132","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,2]]}}}